203 related articles for article (PubMed ID: 16527227)
1. The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial.
Toker MI; Erdem H; Erdogan H; Arici MK; Topalkara A; Arslan OS; Pahsa A
Am J Ophthalmol; 2006 May; 141(5):902-905. PubMed ID: 16527227
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis.
Shiuey Y; Ambati BK; Adamis AP
Ophthalmology; 2000 Aug; 107(8):1512-7. PubMed ID: 10919900
[TBL] [Abstract][Full Text] [Related]
3. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
Sharma A; Gupta R; Ram J; Gupta A
Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.
Weber M; Kodjikian L; Kruse FE; Zagorski Z; Allaire CM
Acta Ophthalmol; 2013 Feb; 91(1):e15-21. PubMed ID: 22970738
[TBL] [Abstract][Full Text] [Related]
5. Treatment of inflamed pterygium and pinguecula with topical indomethacin 0.1% solution.
Frucht-Pery J; Solomon A; Siganos CS; Shvartzenberg T; Richard C; Trinquand C
Cornea; 1997 Jan; 16(1):42-7. PubMed ID: 8985633
[TBL] [Abstract][Full Text] [Related]
6. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis.
Kosrirukvongs P; Luengchaichawange C
J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303
[TBL] [Abstract][Full Text] [Related]
7. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
Duong HV; Westfield KC; Chalkley TH
J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
[TBL] [Abstract][Full Text] [Related]
8. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Trattler W; McDonald M
Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs.
Baudouin C; Nordmann JP; Denis P; Creuzot-Garcher C; Allaire C; Trinquand C
Graefes Arch Clin Exp Ophthalmol; 2002 Nov; 240(11):929-35. PubMed ID: 12486516
[TBL] [Abstract][Full Text] [Related]
10. Artificial tears alone versus 0.45% ketorolac tromethamine with artificial tears for the treatment of acute viral conjunctivitis.
Lyra AF; Bastos LC; Lima RC; Maranhão Lde V; Arantes TE
Arq Bras Oftalmol; 2014 Apr; 77(2):99-102. PubMed ID: 25076474
[TBL] [Abstract][Full Text] [Related]
11. A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis.
Williams CP; Browning AC; Sleep TJ; Webber SK; McGill JI
Eye (Lond); 2005 Jul; 19(7):739-42. PubMed ID: 15359265
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
Sandoval HP; De Castro LE; Vroman DT; Solomon KD
J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
[TBL] [Abstract][Full Text] [Related]
13. Topical ketorolac tromethamine in the reduction of adverse effects of laser in situ keratomileusist.
Kosrirukvongs P; Prabhasawat P; Srivannaboon S; Pornpanich K
J Med Assoc Thai; 2001 Jun; 84(6):804-10. PubMed ID: 11556458
[TBL] [Abstract][Full Text] [Related]
14. Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial.
Kim SJ; Lo WR; Hubbard GB; Srivastava SK; Denny JP; Martin DF; Yan J; Bergstrom CS; Cribbs BE; Schwent BJ; Aaberg TM
Arch Ophthalmol; 2008 Sep; 126(9):1203-8. PubMed ID: 18779478
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
Solomon KD; Donnenfeld ED; Raizman M; Sandoval HP; Stern K; VanDenburgh A; Cheetham JK; Schiffman R;
J Cataract Refract Surg; 2004 Aug; 30(8):1653-60. PubMed ID: 15313287
[TBL] [Abstract][Full Text] [Related]
16. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
Wittpenn JR; Silverstein S; Heier J; Kenyon KR; Hunkeler JD; Earl M;
Am J Ophthalmol; 2008 Oct; 146(4):554-560. PubMed ID: 18599019
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Avunduk AM; Tekelioglu Y; Turk A; Akyol N
Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.
Yaylali V; Demirlenk I; Tatlipinar S; Ozbay D; Esme A; Yildirim C; Ozden S
Acta Ophthalmol Scand; 2003 Aug; 81(4):378-82. PubMed ID: 12859265
[TBL] [Abstract][Full Text] [Related]
19. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study.
Frucht-Pery J; Siganos CS; Solomon A; Shvartzenberg T; Richard C; Trinquand C
Am J Ophthalmol; 1999 Feb; 127(2):148-52. PubMed ID: 10030555
[TBL] [Abstract][Full Text] [Related]
20. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.
Tinkelman DG; Rupp G; Kaufman H; Pugely J; Schultz N
Surv Ophthalmol; 1993; 38 Suppl():133-40. PubMed ID: 8236004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
